Factors influencing short-term re-admission and one-year mortality in patients with chronic obstructive pulmonary disease

Respirology ◽  
2007 ◽  
Vol 12 (4) ◽  
pp. 560-565 ◽  
Author(s):  
Shih-Feng LIU ◽  
Kuan-Chun LIN ◽  
Chien-Hung CHIN ◽  
Yung-Che CHEN ◽  
Hsueh-Wen CHANG ◽  
...  
Keyword(s):  
Chronic Obstructive Pulmonary Disease ◽  
Pulmonary Disease ◽  
Chronic Obstructive ◽  
Short Term ◽  
Obstructive Pulmonary Disease ◽  
Factors Influencing ◽  
One Year

scholarly journals A new short-term mouse model of chronic obstructive pulmonary disease identifies a role for mast cell tryptase in pathogenesis

2013 ◽  
Vol 131 (3) ◽  
pp. 752-762.e7 ◽  
Author(s):  
Emma L. Beckett ◽  
Richard L. Stevens ◽  
Andrew G. Jarnicki ◽  
Richard Y. Kim ◽  
Irwan Hanish ◽  
...  
Keyword(s):  
Chronic Obstructive Pulmonary Disease ◽  
Mast Cell ◽  
Mouse Model ◽  
Pulmonary Disease ◽  
Chronic Obstructive ◽  
Mast Cell Tryptase ◽  
Short Term ◽  
Obstructive Pulmonary Disease

Patient Factors Influencing Respiratory-Related Clinician Actions in Chronic Obstructive Pulmonary Disease Screening

2017 ◽  
Vol 52 (1) ◽  
pp. 94-99 ◽  
Author(s):  
William C. Wadland ◽  
Valentina Bayer Zubek ◽  
Emmanuelle M. Clerisme-Beaty ◽  
Carlos F. Ríos-Bedoya ◽  
Barbara P. Yawn
Keyword(s):  
Chronic Obstructive Pulmonary Disease ◽  
Pulmonary Disease ◽  
Disease Screening ◽  
Chronic Obstructive ◽  
Patient Factors ◽  
Obstructive Pulmonary Disease ◽  
Factors Influencing

Chronic Obstructive Pulmonary Disease (COPD): Factors influencing the occurrence

1979 ◽  
Vol 11 (3) ◽  
pp. 167-171 ◽  
Author(s):  
E. A. McPherson ◽  
G. H. K. Lawson ◽  
Jill R. Murphy ◽  
Janet M. Nicholson ◽  
R. G. BREEZE ◽  
...  
Keyword(s):  
Chronic Obstructive Pulmonary Disease ◽  
Pulmonary Disease ◽  
Chronic Obstructive ◽  
Obstructive Pulmonary Disease ◽  
Factors Influencing

scholarly journals Statins for the Treatment of Pulmonary Hypertension in Patients with Chronic Obstructive Pulmonary Disease

2021 ◽  
Vol 11 ◽  
Author(s):  
Chung-Yu Chen ◽  
Wen-Ting Wu ◽  
Ya-Ling Wang ◽  
Kuang-Ming Liao
Keyword(s):  
Chronic Obstructive Pulmonary Disease ◽  
Pulmonary Hypertension ◽  
Pulmonary Disease ◽  
Chronic Obstructive ◽  
Statin User ◽  
User Group ◽  
Population Database ◽  
Obstructive Pulmonary Disease ◽  
Copd Patients ◽  
One Year

Background: Patients with chronic obstructive pulmonary disease (COPD) are at risk for pulmonary hypertension (PH). The aim of our study was to investigate the benefit of statins for PH in patients with COPD.Methods: The study enrolled 23 million individuals from Taiwan’s population database from January 1, 2002, to December 31, 2017. COPD patients who met the inclusion criteria were enrolled, and patients with lung cancer, less than one year of observation, specific drug therapy for PH and lung transplantation were excluded.Results: A total of 643,131 COPD patients were included in the study, and only 12,308 patients developed PH during follow-up. Based on the inclusion and exclusion criteria, 8,577 PH patients were included in the cohort of patients with PH related to COPD for analysis. According to the definition of statin exposure, the final study population had 1,487 statin users and 7,090 statin non-users. The statin user group had a lower mortality related to PH than the non-user group (3.87 vs. 5.55 per 100 person-years, p < 0.001). The mortality rate for PH in the multivariate analysis (aHR = 0.78, 95% CI = 0.62–0.98, p = 0.046) was significantly lower for statin users than for non-users.Conclusion: Statins seem to benefit patients with PH and COPD.

Sign in / Sign up

Export Citation Format

Share Document